The 4th Quarter 2024 Equine Quarterly Disease Surveillance Report is now available.
Within are key updates, including guidance regarding the unavailability of the Equip Artervac EVA vaccine, a commentary discussing the latest bluetongue cases in livestock and the parallels of this disease's epidemiology with African Horse Sickness, and a Focus Article addressing the emergence of multidrug-resistant Rhodococcus equi. Updates about the 12th International Equine Infectious Diseases Conference taking place in Deauville later this year, and summaries of equine disease outbreaks in the United Kingdom are also included. The go-to source for comprehensive updates on equine health awaits!
Download the report